Volume 64, Issue 1, Pages (January 2016)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Vitamin D for your patients with chronic hepatitis C?
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 61, Issue 3, Pages (September 2014)
The role of Epstein–Barr virus in acute and chronic hepatitis
Liver transplantation using Donation after Cardiac Death donors
Volume 51, Issue 6, Pages (December 2009)
Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Keiji Hirata, Michael H. Nathanson  Gastroenterology 
Immigration and viral hepatitis
Delayed angioplasty after renal thrombosis
Volume 42, Issue 4, Pages (April 2005)
Volume 68, Issue 4, Pages (April 2018)
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
The role of Epstein–Barr virus in acute and chronic hepatitis
Reply to: “DCD consensus and futility in liver transplantation”
Volume 63, Issue 1, Pages (July 2015)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 61, Issue 2, Pages (August 2014)
Volume 44, Issue 5, Pages (May 2006)
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Volume 55, Issue 1, Pages (July 2011)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Vitamin D for your patients with chronic hepatitis C?
Volume 57, Issue 5, Pages (November 2012)
Fibrosis in chronic liver diseases: diagnosis and management
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 4, Pages (April 2006)
Immigration and viral hepatitis
Volume 64, Issue 4, Pages (April 2016)
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Chronic hepatitis B in children and adolescents
Volume 62, Issue 3, Pages (March 2015)
Reviewer Acknowledgment
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Volume 44, Issue 1, Pages (January 2006)
Volume 61, Issue 3, Pages (September 2014)
Comment on the article “Age and liver transplantation”
The relationship between age and fat infiltration in liver and muscle
Ioannis Prionidis, MD, Tom F. Browne  Journal of Vascular Surgery 
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Volume 64, Issue 1, Pages 239-241 (January 2016) Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?  Andrea Schlegel, Philipp Kron, Michelle L. De Oliveira, Pierre-Alain Clavien, Philipp Dutkowski  Journal of Hepatology  Volume 64, Issue 1, Pages 239-241 (January 2016) DOI: 10.1016/j.jhep.2015.09.015 Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Perfusion quality of HOPE in DCD liver grafts. (A) Hypothermic oxygenated perfusion (HOPE) was performed with cold (10°C) UW Gluconate+Fluorescein (rat: 0.1g/50ml, pig & human 0.25g; concentration: 0.5g/5ml) in rat, pig, and discarded human DCD liver grafts through the portal vein (∗). Fluorescence under dark light confirmed complete perfusion of liver grafts within 5min by macroscopy and by histology. (B) Perfusion of DCD pig livers either through the portal vein alone (HOPE∗) or through the portal vein and the hepatic artery (DHOPE++) confirmed no difference in perfusion quality of both approaches as determined by CT-Angiography (UW gluconate+contrast agent: 16mg iodine/3l UW Gluconate). (C)The extrahepatic bile duct in discarded human DCD livers became stained by fluorescein during HOPE through the portal vein alone within 5min (∗). (D) Histologically, samples from the distal main bile duct confirmed the presence of fluorescein in the complete biliar duct wall (∗) after HOPE through the portal vein alone. (E) Extrahepatic bile duct with vascular supply by portal and arterial branches. Journal of Hepatology 2016 64, 239-241DOI: (10.1016/j.jhep.2015.09.015) Copyright © 2015 European Association for the Study of the Liver Terms and Conditions